title: Latissimus dorsi dynamic cardiomyoplasty: role of combined ICD implantation.
abstract: Latissimus dorsi cardiomyoplasty is a promising surgical therapy in some patients with congestive heart failure. Although the mortality in heart failure patients is attributable primarily to heart failure and ventricular arrhythmias, the mechanism of death after cardiomyoplasty is not well characterized. We describe the clinical course of a patient undergoing cardiomyoplasty and discuss the role of combined use with an implantable cardioverter defibrillator. A 39-year-old man with congestive heart failure due to a massive anterior wall myocardial infarction was evaluated for latissimus dorsi cardiomyoplasty. The patient was in NYHA Functional Class III due to heart failure. He did not have any significant exertional or rest angina. During a Naughton stress test, the patient could exercise for 10 minutes, achieving 4 METS. Pulmonary function study showed a peak V O2 of 22.1 mL/min per kg. Radionuclide angiography demonstrated that the anterior wall was akinetic with a left ventricular ejection fraction of 22%. Cardiac hemodynamic studies suggested moderate pulmonary hypertension, elevated wedge pressure, and suboptimal response to exercise. A Holter recording showed frequent ventricular extrasystoles. Cardiomyoplasty was preferred to heart transplantation because the patient did not have end-stage heart failure. Postoperatively, the patient required low doses of dopamine. He developed recurrent, sustained, and hemodynamically significant episodes of ventricular tachycardia. He was treated with a combination of amiodarone and procainamide. He died 2 days postoperatively with ventricular fibrillation. Ventricular arrhythmias are a major cause of death in patients with heart failure. Latissimus dorsi cardiomyoplasty appears to be a promising but unproven therapy in such patients.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Division of Cardiology, University Hospital, London, Canada.
authors.forename: R K
authors.initials: RK
authors.lastname: Thakur
authors.forename: L H
authors.initials: LH
authors.lastname: Chow
authors.forename: G M
authors.initials: GM
authors.lastname: Guiraudon
authors.forename: W J
authors.initials: WJ
authors.lastname: Kostuk
authors.forename: J E
authors.initials: JE
authors.lastname: Brown
authors.forename: P V
authors.initials: PV
authors.lastname: Pflugfelder
authors.forename: C M
authors.initials: CM
authors.lastname: Guiraudon
mesh_terms: D000328:Adult; D018421:Cardiomyoplasty; D017147:Defibrillators, Implantable; D017809:Fatal Outcome; D006333:Heart Failure / Q000601:surgery*; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D017180:Tachycardia, Ventricular / Q000209:etiology